1. "Thoracic Oncology"
Formats
  1. Meeting Abstract (1694)
  2. Journal Article (1416)
  3. Review (80)
  4. Editorial (56)
  5. Book Section (35)
  6. Guidelines (24)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3351)
  2. Solid Tumor Oncology Division (3351)
  3. Thoracic Oncology (3351)
  4. GSK Faculty (1056)
  5. Department of Pathology and Laboratory Medicine (797)
  6. Human Oncology and Pathogenesis Program (625)

More Groups

People
  1. Mark Kris (869)
  2. Alexander Drilon (631)
  3. Gregory Riely (599)
  4. Charles Rudin (488)
  5. Marc Ladanyi (414)
  6. Matthew Hellmann (411)

More People

Years
  1. 2025 (73)
  2. 2024 (270)
  3. 2023 (272)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (692)
  2. Journal of Thoracic Oncology (513)
  3. Annals of Oncology (277)
  4. Clinical Cancer Research (156)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (769)
  2. Elsevier Inc. (734)
  3. American Association for Cancer Research (383)
  4. Oxford University Press (350)
  5. Nature Publishing Group (148)
  6. Elsevier Science, Inc. (78)

More Publishers

Results (3351)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Preliminary clinical activity of repotrectinib (TPX-0005) in advanced ROS1 fusion-positive non-small cell lung cancer
    Meeting Abstract

    Ou, S.; Cho, B. C.; Kim, D.; Drilon, A.; Lee, J.; Lin, J.; Zhu, V.; Ahn, M.; Camidge, D. R.; Shanna Stopatschinskaja, S.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Phase 1 study of the anti-HER3 antibody drug conjugate U3-1402 in metastatic or unresectable EGFR-mutant NSCLC
    Meeting Abstract

    Jänne, P.; Yu, H.; Johnson, M.; Steuer, C.; Vigliotti, M.; Shipitofsky, N.; Guevara, F. M.; Chen, S.; Yu, C.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Phase 1 study of the AXL inhibitor DS-1205c in combination with osimertinib in subjects with metastatic or unresectable EGFR-mutant NSCLC
    Meeting Abstract

    Jänne, P.; Yu, H.; Shipitofsky, N.; Vigliotti, M.; Goldberg, T.; Li, J.; Mcgill, J.; Zhang, H.; Yu, C.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Adjuvant targeted therapy following standard adjuvant therapy for resected NSCLC: An initial report from ALCHEMIST (Alliance A151216)
    Meeting Abstract

    Oxnard, G.; Mandrekar, S.; Hillman, S.; Tan, A.; Govindan, R.; Wigle, D.; Malik, S.; Watt, C.; Gerber, D.; Chaft, J.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Evaluation of PD-L1-stained tumor cells via the 22C3 and SP-142 antibodies in cohort of patients treated on KEYNOTE-001
    Meeting Abstract

    Lisberg, A.; Hu-Lieskovan, S.; Grogan, T.; Carroll, J.; Shintaku, P.; Han, M.; Slamon, D.; Dubinett, S.; Goldman, J.; Elashoff, D.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • VISTA is highly expressed in malignant pleural mesothelioma (MPM) and independent of PD-L1 expression
    Meeting Abstract

    Zauderer, M.; Muller, S.; Lai, W.; Ni, A.; Jungbluth, A.; Ginsberg, M.; Daly, R.; Hellmann, M.; Ladanyi, M.; Sauter, J.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Genetic predictors of response to chemoradiation in stage III non-small-cell lung cancer
    Meeting Abstract

    Luo, L.; Samstein, R.; Dick-Godfrey, R.; Sidiqi, B.; Wang, C.; Oro, F.; Sonnick, M.; Paik, P.; Chaft, J.; Rimner, A.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Phase 3 study of pemetrexed-platinum with or without pembrolizumab for TKI-resistant/EGFR-mutated advanced NSCLC: KEYNOTE-789
    Meeting Abstract

    Riely, G.; Hui, R.; Carbone, D.; Park, K.; Carrigan, M.; Xu, X.; Dang, T.; Yang, J. C. H.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Rapid, robust and durable responses to larotrectinib in patients with TRK fusion non-small cell lung cancer
    Meeting Abstract

    Farago, A.; Kummar, S.; Ibabekci, S.; Corsi-Travali, S.; Cruickshank, S.; Cox, M.; Ku, N.; Drilon, A.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Detecting HER2 alterations by next generation sequencing (NGS) in patients with advanced NSCLC from the United States and China
    Meeting Abstract

    Xu, C.; Zhang, Y.; Liu, D.; Shen, R.; Razavi, P.; Liu, S.; Sun, H.; Offin, M.; Drilon, A.; Rudin, C.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save